GLP-1 Medicine Mounjaro May Be First Drug to Ease Sleep Apnea [Video]

Key Takeaways

A diabetes & weight loss drug has been shown to help obese people who have sleep apneaThe finding could be good news for people who don’t like wearing a CPAP mask to bedResearchers hailed the finding as a milestone in treatment of both sleep apnea and obesity

FRIDAY, June 21, 2024 (HealthDay News) — A medication used to manage type 2 diabetes has been found effective in treating sleep apnea.

The worldwide clinical trial demonstrates that tirzepatide significantly lowers breathing interruptions during sleep, a key indicator of the severity of a patient’s obstructive sleep apnea (OSA).

Tirzepatide is one of the class of blockbuster GLP-1 medicines, sold as Mounjaro to fight diabetes and as Zepbound to help with weight loss.

“This study marks a significant milestone in the treatment of OSA, offering a promising new therapeutic option that addresses both respiratory and metabolic complications,” said study leader Dr. Atul Malhotra, director of sleep medicine at UC …